Luther King Capital Management (LKCM)’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $459K | Sell |
10,750
-40,481
| -79% | -$2.2M | ﹤0.01% | 498 |
|
|
2026
Q1 | $3.21M | Sell |
51,231
-1,390
| -3% | -$111K | 0.01% | 303 |
|
|
2025
Q4 | $5.02M | Buy |
52,621
+5,770
| +12% | +$566K | 0.02% | 258 |
|
|
2025
Q3 | $4.57M | Buy |
46,851
+36,454
| +351% | +$3.78M | 0.02% | 260 |
|
|
2025
Q2 | $1.12M | Buy |
10,397
+87
| +0.8% | +$8.8K | ﹤0.01% | 398 |
|
|
2025
Q1 | $1.04M | Buy |
10,310
+60
| +0.6% | +$6.04K | ﹤0.01% | 405 |
|
|
2024
Q4 | $916K | Sell |
10,250
-13
| -0.1% | -$1.14K | ﹤0.01% | 410 |
|
|
2024
Q3 | $860K | Buy |
10,263
+73
| +0.7% | +$5.75K | ﹤0.01% | 420 |
|
|
2024
Q2 | $785K | Hold |
10,190
| – | – | ﹤0.01% | 426 |
|
|
2024
Q1 | $698K | Hold |
10,190
| – | – | ﹤0.01% | 440 |
|
|
2023
Q4 | $589K | Hold |
10,190
| – | – | ﹤0.01% | 441 |
|
|
2023
Q3 | $538K | Sell |
10,190
-164
| -2% | -$8.6K | ﹤0.01% | 456 |
|
|
2023
Q2 | $560K | Buy |
10,354
+79
| +0.8% | +$4.13K | ﹤0.01% | 464 |
|
|
2023
Q1 | $514K | Buy |
10,275
+25
| +0.2% | +$1.18K | ﹤0.01% | 460 |
|
|
2022
Q4 | $474K | Sell |
10,250
-149
| -1% | -$6.45K | ﹤0.01% | 460 |
|
|
2022
Q3 | $403K | Hold |
10,399
| – | – | ﹤0.01% | 472 |
|
|
2022
Q2 | $388K | Sell |
10,399
-538
| -5% | -$21.9K | ﹤0.01% | 508 |
|
|
2022
Q1 | $484K | Buy |
10,937
+239
| +2% | +$10.4K | ﹤0.01% | 483 |
|
|
2021
Q4 | $454K | Sell |
10,698
-158
| -1% | -$6.64K | ﹤0.01% | 505 |
|
|
2021
Q3 | $471K | Buy |
10,856
+206
| +2% | +$9.11K | ﹤0.01% | 500 |
|
|
2021
Q2 | $455K | Sell |
10,650
-67
| -0.6% | -$2.82K | ﹤0.01% | 513 |
|
|
2021
Q1 | $414K | Sell |
10,717
-276
| -3% | -$10.4K | ﹤0.01% | 478 |
|
|
2020
Q4 | $395K | Sell |
10,993
-15,539
| -59% | -$560K | ﹤0.01% | 474 |
|
|
2020
Q3 | $1.01M | Hold |
26,532
| – | – | 0.01% | 328 |
|
|
2020
Q2 | $932K | Sell |
26,532
-1,380
| -5% | -$49.7K | 0.01% | 328 |
|
|
2020
Q1 | $911K | Sell |
27,912
-675
| -2% | -$26.4K | 0.01% | 314 |
|
|
2019
Q4 | $1.29M | Buy |
28,587
+281
| +1% | +$11.8K | 0.01% | 325 |
|
|
2019
Q3 | $1.15M | Buy |
28,306
+10,010
| +55% | +$424K | 0.01% | 329 |
|
|
2019
Q2 | $786K | Sell |
18,296
-21,466
| -54% | -$826K | 0.01% | 356 |
|
|
2019
Q1 | $1.53M | Hold |
39,762
| – | – | 0.01% | 298 |
|
|
2018
Q4 | $1.41M | Buy |
39,762
+22
| +0.1% | +$798 | 0.01% | 293 |
|
|
2018
Q3 | $1.53M | Buy |
39,740
+15,205
| +62% | +$531K | 0.01% | 314 |
|
|
2018
Q2 | $802K | Buy |
+24,535
| New | +$740K | 0.01% | 373 |
|
Other funds holding BSX
Luther King Capital Management (LKCM)'s BSX Position: Q2 2026 in Review
Luther King Capital Management (LKCM) reduced its Boston Scientific (BSX) stake by 79% in Q2 2026, selling an estimated $2.2M and leaving 10,750 shares worth $459K. The position accounts for ﹤0.01% of the portfolio, ranked #498.
Luther King Capital Management (LKCM) first reported a position in BSX in Q2 2018 and has held it in 33 quarters since. The position peaked at $5.02M in Q4 2025. 1,487 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Luther King Capital Management (LKCM) held 10,750 shares of Boston Scientific worth $459K as of Q2 2026.
- Luther King Capital Management (LKCM) sold 40,481 Boston Scientific shares in Q2 2026, an estimated $2.2M.
- Boston Scientific made up ﹤0.01% of Luther King Capital Management (LKCM)'s portfolio in Q2 2026, its #498 holding.
- Luther King Capital Management (LKCM) first reported a position in Boston Scientific in Q2 2018 and has held it in 33 quarters since.
- Luther King Capital Management (LKCM)'s Boston Scientific position peaked at $5.02M in Q4 2025.
- 1,487 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Luther King Capital Management (LKCM)'s 13F filing for Q2 2026, filed 10 Aug 2026.